home / stock / apli:cc / apli:cc news

APLI:CC News and Press, Appili Therapeutics Inc. From 05/17/22

Stock Information
Company Name: Appili Therapeutics Inc.
Stock Symbol: APLI:CC
Market: TSXC
Website: appilitherapeutics.com
Menu
APLI:CC APLI:CC Quote APLI:CC Short APLI:CC News APLI:CC Articles APLI:CC Message Board
Get APLI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
APLI:CC - Appili Therapeutics Announces Overnight Marketed Equity Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Appili Therapeutics Inc. (TSX: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today ...
APLI:CC - Appili Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today announced that Stéphane Paquette, Vice President, Corporate Development, will present at...

APLI:CC - Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneous Leishmaniasis

Topical formulation of paromomycin ATI-1801 already shown to be safe and effective against the disfiguring disease in Phase 3 study ATI-1801 may be eligible for tropical disease priority review voucher if approved by FDA Appili Therapeutics Inc. (TSX: APLI; OTCQX: AP...

APLI:CC - Appili Therapeutics Announces Non-Convertible Secured Loan of US$3.6 Million and License and Distribution Agreement with Long Zone Holdings

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious di...
Previous 10 Next 10